Cardiac Imaging

May 4, 2026 — The American Society of Echocardiography (ASE) has released a new guideline that provides guidance for cardiovascular ultrasound imaging professionals to better recognize and understand cardiac ultrasound artifacts…

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next-generation Ultreon 3.0 software.

March 25,  2026 A Penn Medicine–led team has developed a first‑of‑its‑kind artificial intelligence system that interprets cardiac MRI scans with performance approaching expert clinicians.

Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the latest computer-assisted detection (CADe) radiography solution from Qure.ai.

Jan. 7, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has partnered with Jefferson Health, one of the largest academic health systems in the United States, in a clinical study to advance rapid incorporation of diagnostic-quality FoCUS echocardiogram workflows.